• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发血友病关节健康评分2.1的新评分方案。

Developing a new scoring scheme for the Hemophilia Joint Health Score 2.1.

作者信息

Ribeiro Tiago, Abad Audrey, Feldman Brian M

机构信息

Schulich School of Medicine & Dentistry Western University London Ontario Canada.

Child Health Evaluative Sciences Program, Research Insititute The Hospital for Sick Children Toronto Ontario Canada.

出版信息

Res Pract Thromb Haemost. 2019 May 20;3(3):405-411. doi: 10.1002/rth2.12212. eCollection 2019 Jul.

DOI:10.1002/rth2.12212
PMID:31294328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6611477/
Abstract

BACKGROUND

The Hemophilia Joint Health Score (HJHS) is a validated outcome tool developed for the assessment of joint health in people with hemophilia. The ordinal joint score assesses 9 items in 6 index joints. It is recognized as an optimal measurement of arthropathy in children and young adults. The aim of this study was to develop an updated scoring system for the HJHS that may overcome the limitations of its current ordinal scoring structure.

METHODS

A survey was developed using 1000Minds decision-making software. Respondents were provided with discrete choice tasks of ranking alternatives to determine the preference weight, or relative importance, placed on different criteria for each HJHS item. The survey was distributed to an anonymous sample of health care professionals with extensive experience in the physical examination of joints in people with hemophilia.

RESULTS

A total of 64 musculoskeletal health care professionals participated; with a 64% survey completion rate. The HJHS item weights provide a sum to 1.0; the highest-ranked item was extension loss (0.139) followed by swelling (0.121), whereas the lowest was duration of swelling (0.057) followed by muscle atrophy (0.08). Compared to the original, the relative efficiency of the new score was 5.4.

CONCLUSIONS

Observed differences in preference weights for HJHS items highlight the potential under- or overestimation of true joint health using the current ordinal scoring system. An updated scoring system using weighted items may improve the precision of HJHS assessment, leading to improved clinical management of joint health, while providing a robust research tool.

摘要

背景

血友病关节健康评分(HJHS)是一种经过验证的结局工具,用于评估血友病患者的关节健康状况。序数关节评分评估6个指标关节中的9个项目。它被认为是儿童和年轻成人关节病的最佳测量方法。本研究的目的是开发一种更新的HJHS评分系统,以克服其当前序数评分结构的局限性。

方法

使用1000Minds决策软件开展一项调查。向受访者提供对备选方案进行排序的离散选择任务,以确定对每个HJHS项目不同标准的偏好权重或相对重要性。该调查分发给在血友病患者关节体格检查方面具有丰富经验的医疗保健专业人员的匿名样本。

结果

共有64名肌肉骨骼保健专业人员参与;调查完成率为64%。HJHS项目权重总和为1.0;排名最高的项目是伸展受限(0.139),其次是肿胀(0.121),而最低的是肿胀持续时间(0.057),其次是肌肉萎缩(0.08)。与原始评分相比,新评分的相对效率为5.4。

结论

HJHS项目偏好权重的观察差异突出了使用当前序数评分系统可能低估或高估真实关节健康状况的可能性。使用加权项目的更新评分系统可能会提高HJHS评估的精度,从而改善关节健康的临床管理,同时提供一个强大的研究工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f2/6611477/0b3f7692b6c7/RTH2-3-405-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f2/6611477/96c8e34549df/RTH2-3-405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f2/6611477/0b3f7692b6c7/RTH2-3-405-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f2/6611477/96c8e34549df/RTH2-3-405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f2/6611477/0b3f7692b6c7/RTH2-3-405-g002.jpg

相似文献

1
Developing a new scoring scheme for the Hemophilia Joint Health Score 2.1.开发血友病关节健康评分2.1的新评分方案。
Res Pract Thromb Haemost. 2019 May 20;3(3):405-411. doi: 10.1002/rth2.12212. eCollection 2019 Jul.
2
Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score.验证国际血友病预防治疗研究组的新儿科关节评分系统:血友病关节健康评分的有效性。
Arthritis Care Res (Hoboken). 2011 Feb;63(2):223-30. doi: 10.1002/acr.20353.
3
Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS.评估国际血友病关节健康评分(HJHS)结果并结合专家意见:更简短的 HJHS 选项。
Haemophilia. 2020 Nov;26(6):1072-1080. doi: 10.1111/hae.14180. Epub 2020 Oct 15.
4
Impact of the HEAD-US Scoring System for Observing the Protective Effect of Prophylaxis in Hemophilia Patients: A Prospective, Multicenter, Observational Study.《HEAD-US 评分系统对血友病患者预防保护效果观察的影响:一项前瞻性、多中心、观察性研究》。
Turk J Haematol. 2021 Jun 1;38(2):101-110. doi: 10.4274/tjh.galenos.2021.2020.0717. Epub 2021 Jan 29.
5
Using the Hemophilia Joint Health Score for assessment of children: Reliability of the Spanish version.使用血友病关节健康评分评估儿童:西班牙语版本的可靠性。
Physiother Theory Pract. 2019 Apr;35(4):341-347. doi: 10.1080/09593985.2018.1443356. Epub 2018 Feb 27.
6
Correlating clinical and radiological assessment of joints in haemophilia: results of a cross sectional study.血友病关节的临床与影像学评估相关性:一项横断面研究结果
Haemophilia. 2016 Nov;22(6):925-933. doi: 10.1111/hae.13023. Epub 2016 Jul 7.
7
HJHS 2.1 and HEAD-US assessment in the hemophilic joints: How do their findings compare?HJHS 2.1 和 HEAD-US 在血友病性关节中的评估:它们的发现有何不同?
Blood Coagul Fibrinolysis. 2020 Sep;31(6):387-392. doi: 10.1097/MBC.0000000000000934.
8
The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study.血友病关节健康评分2.1版在成年患者中的验证研究:一项多中心国际研究。
Res Pract Thromb Haemost. 2022 Mar 25;6(2):e12690. doi: 10.1002/rth2.12690. eCollection 2022 Feb.
9
Muscle strength and joint health in children with hemophilia: a cross-sectional study.儿童血友病患者的肌肉力量和关节健康:一项横断面研究。
Turk J Pediatr. 2020;62(4):606-613. doi: 10.24953/turkjped.2020.04.010.
10
Using routine Haemophilia Joint Health Score for international comparisons of haemophilia outcome: standardization is needed.使用血友病关节健康常规评分进行血友病治疗结果的国际比较:需要标准化。
Haemophilia. 2016 Jan;22(1):142-7. doi: 10.1111/hae.12755. Epub 2015 Jul 14.

引用本文的文献

1
Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderReal.转换为聚乙二醇化重组人凝血因子VIII后评估甲型血友病患者关节健康的非干预性研究:探索者Real研究设计
Res Pract Thromb Haemost. 2024 Mar 1;8(2):102363. doi: 10.1016/j.rpth.2024.102363. eCollection 2024 Feb.
2
Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.用于预防先天性 A 型或 B 型血友病患者出血的非凝血因子治疗方法。
Cochrane Database Syst Rev. 2024 Feb 27;2(2):CD014544. doi: 10.1002/14651858.CD014544.pub2.
3
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial.

本文引用的文献

1
Monitoring joint health in haemophilia: Factors associated with deterioration.监测血友病患者的关节健康:与病情恶化相关的因素。
Haemophilia. 2017 Nov;23(6):934-940. doi: 10.1111/hae.13327. Epub 2017 Sep 5.
2
Preference-based valuation of treatment attributes in haemophilia A using web survey.基于网络调查的血友病 A 治疗属性偏好评估。
Haemophilia. 2017 Nov;23(6):894-903. doi: 10.1111/hae.13322. Epub 2017 Aug 29.
3
Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia Study.
依美珠单抗预防治疗血友病 A 婴儿患者(HAVEN 7):一项 3b 期开放标签试验的主要分析。
Blood. 2024 Apr 4;143(14):1355-1364. doi: 10.1182/blood.2023021832.
4
Effectiveness of myofascial therapy on hemophilic arthropathy: A systematic review and meta-analysis of clinical trials.肌筋膜疗法对血友病性关节病的疗效:一项临床试验的系统评价和荟萃分析
Heliyon. 2022 Dec 22;8(12):e12552. doi: 10.1016/j.heliyon.2022.e12552. eCollection 2022 Dec.
5
Outcome of Joint Aspiration in Acute Knee Haemarthrosis in a Haemophilic Joint: A Prospective Randomised Controlled Trial in 120 Patients in a Tertiary Haemophilia Care Centre.血友病关节急性膝关节积血时关节穿刺的结果:在一家三级血友病护理中心对120例患者进行的前瞻性随机对照试验。
Indian J Orthop. 2022 Sep 16;56(12):2060-2065. doi: 10.1007/s43465-022-00745-x. eCollection 2022 Dec.
6
The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients.血友病患者预防终身优化的五大基石的局限性与未满足需求
TH Open. 2022 Nov 11;6(4):e365-e377. doi: 10.1055/s-0042-1757745. eCollection 2022 Oct.
7
Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes.对儿童重度甲型血友病患者进行血栓弹力图和凝血酶生成评估的结果差异很大,且无法预测临床表型。
Res Pract Thromb Haemost. 2022 Sep 26;6(6):e12800. doi: 10.1002/rth2.12800. eCollection 2022 Aug.
8
The evolution of physiotherapy in the multidisciplinary management of persons with haemophilia (PWH): A scoping review.物理治疗在血友病患者(PWH)多学科管理中的演变:范围综述。
Haemophilia. 2023 Jan;29(1):11-20. doi: 10.1111/hae.14661. Epub 2022 Sep 27.
9
The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study.血友病关节健康评分2.1版在成年患者中的验证研究:一项多中心国际研究。
Res Pract Thromb Haemost. 2022 Mar 25;6(2):e12690. doi: 10.1002/rth2.12690. eCollection 2022 Feb.
10
Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS.评估国际血友病关节健康评分(HJHS)结果并结合专家意见:更简短的 HJHS 选项。
Haemophilia. 2020 Nov;26(6):1072-1080. doi: 10.1111/hae.14180. Epub 2020 Oct 15.
资源受限国家和非资源受限国家血友病疾病负担的比较:圣保罗-多伦多血友病研究。
Haemophilia. 2017 Sep;23(5):682-688. doi: 10.1111/hae.13230. Epub 2017 Apr 24.
4
Economic costs of hemophilia and the impact of prophylactic treatment on patient management.血友病的经济成本以及预防性治疗对患者管理的影响。
Am J Manag Care. 2016 Apr;22(5 Suppl):s126-33.
5
The past and future of haemophilia: diagnosis, treatments, and its complications.血友病的过去和未来:诊断、治疗及其并发症。
Lancet. 2016 Jul 9;388(10040):187-97. doi: 10.1016/S0140-6736(15)01123-X. Epub 2016 Feb 18.
6
Patient and parent preferences for characteristics of prophylactic treatment in hemophilia.血友病患者及家长对预防性治疗特征的偏好。
Patient Prefer Adherence. 2015 Nov 23;9:1687-94. doi: 10.2147/PPA.S92520. eCollection 2015.
7
A critical review of scoring options for clinical measurement tools.临床测量工具评分选项的批判性综述。
BMC Res Notes. 2015 Oct 28;8:612. doi: 10.1186/s13104-015-1561-6.
8
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.运用德尔菲法和1000Minds共识法制定痛风初步缓解标准
Arthritis Care Res (Hoboken). 2016 May;68(5):667-72. doi: 10.1002/acr.22741.
9
Assessment of outcomes.结果评估。
Haemophilia. 2014 May;20 Suppl 4:114-20. doi: 10.1111/hae.12426.
10
Do patient preferences for core outcome domains for chronic gout studies support the validity of composite response criteria?患者对慢性痛风研究核心结局指标的偏好是否支持综合反应标准的有效性?
Arthritis Care Res (Hoboken). 2013 Aug;65(8):1259-64. doi: 10.1002/acr.21955.